CompletedNCT04116528
Ketamine and Buprenorphine for Suicidal Thoughts in Depression
About this title
Read the official source — NCT04116528Medication studyAges 18–70United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- StanfordSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: August 1, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- Stanford University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04116528
- Official title
Show the full official title
Opiate Suicide Study in Patients With Major Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Stanford
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stanford University, a university.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
